- Accueil >
- Publications >
- Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study
Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study
Auteurs
Jean-Philippe Jacquin, Lionel Uwer, Alexia Savignoni, Jean-Marc Ferrero, Alain Lortholary, David Solub, Flore Delaporte, Nassera Chalabi, Sophie Pibre, Yazid Belkacemi